Tranont Revenue and Competitors

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Tranont's estimated annual revenue is currently $356.5M per year.(i)
  • Tranont's estimated revenue per employee is $378,000

Employee Data

  • Tranont has 943 Employees.(i)
  • Tranont grew their employee count by 8% last year.

Tranont's People

NameTitleEmail/Phone
1
CEO and FounderReveal Email/Phone
2
VP Sales and GrowthReveal Email/Phone
3
VP MarketingReveal Email/Phone
4
VP, Culture and CommunityReveal Email/Phone
5
Director Corporate FinanceReveal Email/Phone
6
Supply Chain DirectorReveal Email/Phone
7
Associate Director Content StrategyReveal Email/Phone
8
Director Tranont LifeReveal Email/Phone
9
Chief Financial OfficerReveal Email/Phone
10
Director, Projects and System DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.1M336%N/AN/A
#2
$8.4M39-2%N/AN/A
#3
$61.8M20812%N/AN/A
#4
$12.9M530%N/AN/A
#5
$9.9M46N/AN/AN/A
#6
$7.3M343%N/AN/A
#7
$208.6M6188%N/AN/A
#8
$17M7030%N/AN/A
#9
$135.7M4021%N/AN/A
#10
$476.1M123310%$580MN/A
Add Company

What Is Tranont?

We’re on a mission to impact one billion lives for good over our first 20 years. Through personalized health and wealth education, we provide instruction, products, and services to help families reach their goals. \nUsing a direct-sales model, neighbors are helping neighbors improve their health, create more wealth, and leave a lasting impact in their communities.

keywords:N/A

N/A

Total Funding

943

Number of Employees

$356.5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tranont News

2022-04-13 - Most Blood Cancer Drug Trials Are Not Randomized, Use Surrogate ...

2022;18:101374. doi:10.1016/j.tranon.2022.101374. 3. Del Paggio JC, Berry JS, Hopman WM, et al. Evolution of the randomized clinical trial...

2022-03-30 - Mutational Analysis Of BRCA1/BRCA2 Genes in Breast Cancer ...

2021;14(8):101104. doi:10.1016/j.tranon.2021.101104. 12. Kin G, Marks JH, Mandell JB; New York Breast Cancer Study Group.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$189.6M9471%$277M
#2
$75M11205%N/A
#3
$251.1M12540%$419.1M
#4
$256.9M1283-1%$419.1M
#5
$281.4M1386N/AN/A